Hemostasis and Thrombosis
methionine metabolism, are known to influence plasma Hcy concentrations.
In vitro data suggested that NO may modulate Hcy concentration either by direct inhibition of methionine synthase or via an indirect effect on folate catabolism (8, 9 ) . Common polymorphisms in the gene encoding for endothelial nitric oxide synthase (eNOS) influence the production and functional activity of the enzyme. A substitution of guanine to thymine at nucleotide 894 in exon 7 of the eNOS gene (894GϾT), which leads to an amino acid change from Glu to Asp at codon 298 (also called Glu298Asp) is associated with reduced basal NO production (10 ) . Evidence that this polymorphism is associated with atherosclerosis has been found (11) (12) (13) . A clinical study indicated that the eNOS 894GϾT polymorphism may represent a risk factor for increased plasma Hcy in healthy persons (14 ) , whereas other recent studies did not confirm a role for this polymorphism in affecting Hcy concentrations (15, 16 ) .
Another polymorphism, resulting from a thymine being replaced by a cytosine at nucleotide Ϫ786 (Ϫ786TϾC) and responsible for a reduction in the eNOS gene promoter activity, has been associated with atherosclerotic disease (17, 18 ) . Finally, a variable number of tandem repeats (VNTR) 27-bp repeat polymorphism (4a4b) is associated with altered plasma NO concentrations (19 ) and has been found to be responsible for variations in the genetic control of plasma nitrite and nitrate concentrations (20 ) . No data are available on the influence of the eNOS Ϫ786TϾC and 4a4b polymorphisms on Hcy concentrations.
We undertook this study to determine whether plasma Hcy concentrations are influenced by these 3 eNOS gene polymorphisms in addition to the methylenetetrahydrofolate reductase (MTHFR) 677CϾT polymorphism and circulating concentrations of vitamins.
Materials and Methods study design
Blood samples were obtained from 1287 unrelated persons (708 males and 584 females; median age, 60 years; range, 20 -78 years) recruited between 2001 and 2003 from the staff of the University of Florence, from their partners and friends (n ϭ 544), and from a population study, "Progetto Nutrizione per la Salute e la Prevenzione di Malattia" (21 ) , conducted between 2002 and 2004 and aimed at evaluating lifestyle and dietary habits of clinically healthy persons living in Florence, Italy (n ϭ 743). A detailed interview concerning personal and family histories was performed by expert physicians in conjunction with a physical examination to identify symptom-free individuals and to exclude those suspected of having any kind of vascular disease. Current smoking status was determined at the time of blood collection.
The participants were considered to have hypertension if they had been diagnosed according to the guidelines of the European Society of Hypertension/European Society of Cardiology (22 ) 
detection of gene polymorphisms
eNOS and MTHFR 677CϾT polymorphisms were analyzed from genomic DNA extracted from peripheral blood leukocytes by a QIAamp Blood Kit (Qiagen). The MTHFR 677CϾT polymorphism was analyzed as described previously (25 ) .
eNOS Ϫ786TϾC polymorphism
The eNOS Ϫ786TϾC polymorphism was analyzed by PCR with restriction fragment length polymorphism analysis. PCR was performed with the primers 5Ј-GTGTAC-CCCACCTGCATTCT-3Ј (sense) and 5Ј-CCCAGCAAG-GATGTAGTGAC-3Ј (antisense), and DNA (100 ng) was amplified in a final volume of 20 L at an annealing temperature of 60°C in a DNA thermal cycler. The PCR product (306 bp) was digested with 1 U of NaeI restriction enzyme (Turbo Nae I; Promega) at 37°C for 4 h to obtain fragments of 225 and 81 bp. The PCR digestion products were then subjected to electrophoresis on 2% agarose gels.
eNOS 4a4b polymorphism
The eNOS 4a4b polymorphism was analyzed by PCR amplification. PCR was performed with the primers 5Ј-CTATGGTAGTGCCTTGGCTGGAGG-3Ј (sense) and 5Ј-ACCGCCCAGGGAACTCCGCT-3Ј (antisense), and DNA was amplified in a final volume of 20 L at an annealing temperature of 58°C. The amplified products were analyzed by electrophoresis on a 3.5% agarose gel. The common allele (4b) amplicon size was 210 bp, whereas the rare allele (4a) amplicon size was 183 bp.
eNOS 894GϾT polymorphism eNOS 894GϾT polymorphism detection was performed by real-time fluorescence PCR on a LightCycler instrument (Roche Diagnostics).
PCR and melting curve determinations were performed in a final volume of 20 L with 10 pmol of each primer [NOSF (5Ј-CACTCCCCACAGCTCTGCAT-3Ј) and NOSR (5Ј-CAATCCCTTTGGTGCTCACG-3Ј)] and 4 pmol of each probe (anchor and sensor probes). The anchor probe (5Ј-LC Red 640-CCTTCTGCCCCCCGAG-CTGGTCC-3Ј-P) was 5Ј-labeled with the LC-Red 640 fluorophore and phosphorylated (P) at its 3Ј end to prevent probe elongation by the Taq polymerase. The sensor probe, which matches the rare allele sequence (5Ј-CCCCAGATGATCCCCCAGAACTC-3ЈFLU; the underlined base indicates the polymorphism), was labeled with fluorescein. DNA was amplified at an annealing temperature of 62°C. The amplicon size was 206 bp.
The typical melting curve pattern for the mutant is a single melting peak at a temperature of 65.5°C. For the wild type, the plot gives a single melting peak at a temperature of 60.5°C. Heterozygous patients have 2 melting peaks, at 60.5 and 65.5°C (26 ) .
statistical analysis
Data are reported as the mean (SD) or median and range. Statistical analysis was performed with the SPSS statistical package (Ver. 11.5) for Windows (SPSS Inc.). The 2 test was used to test for deviation of genotype distributions from Hardy-Weinberg equilibrium.
Log-transformed values for Hcy, serum creatinine, and circulating vitamin B 6 , B 12 , and folate were used in the analysis and were back-transformed for data presentation. We used a dominant model of inheritance, which assumed that the rare allele was dominant (e.g., eNOS 4a4a ϩ 4a4b vs 4b4b) because no data are available about a dose-dependent effect of the rare eNOS gene variants on eNOS activity. To evaluate the relationship between the MTHFR 677CϾT polymorphism and Hcy concentrations, we used a general linear models analysis.
The study population was divided into tertiles of circulating Hcy (Ͻ10. 
Results
Of the participants 385 (29.9%) were smokers; 328 (25.5%) had hypertension, 249 (19.3%) had dyslipidemia, and 57 (4.4%) had diabetes. The values for analytes related to Hcy metabolism are reported in Table 1 .
Genotype distributions and allele frequencies for the eNOS Ϫ786TϾC, 894GϾT, and 4a4b and the MTHFR 677CϾT polymorphisms (Table 2) were in Hardy-Weinberg equilibrium.
The eNOS Ϫ786C variant, but not the 894T and 4a rare variants, influenced plasma Hcy concentrations. The Fig. 1 .
To evaluate the possible influence of eNOS polymorphisms on the presence of increased Hcy, we analyzed tertiles of Hcy. Univariate multinomial logistic regression analysis showed that persons carrying the eNOS Ϫ786C allele, but not the eNOS 894T and 4a alleles, had a significant risk of having Hcy concentrations in the third tertile (Table 3 ). After adjustment for variables known to influence plasma Hcy concentrations (age; sex; serum creatinine; circulating folate, vitamin B 6 , and vitamin B 12 concentrations; and MTHFR 677TT genotype), the eNOS Ϫ786TϾC polymorphism remained associated with Hcy concentrations (Table 3 ). The MTHFR 677CϾT polymorphism significantly influenced plasma Hcy after adjustment for all confounding variables (age; sex; serum creatinine; circulating folate, vitamin B 6 , and vitamin B 12 concentrations; and smoking habits).
The presence of both the eNOS Ϫ786TϾC and the MTHFR 677CϾT polymorphisms did not have an additive effect in increasing the risk of having Hcy in the third tertile (OR ϭ 2.9; 95% CI, 1.4 -6.2; P ϭ 0.005). Similarly, no significant influence of the concurrent presence of Ϫ786TϾC and the 2 other eNOS polymorphisms on Hcy was demonstrated [Ϫ786TϾC/4a4b, OR ϭ 1.3 (95% CI, 0.7-2.2; P ϭ 0.4); Ϫ786TϾC/894GϾT, OR ϭ 1.4 (95% CI, 0.8 -2.3; P ϭ 0.2)].
Because of the relevant roles of circulating vitamins and the MTHFR 677CϾT polymorphism in Hcy metabolism, we subgrouped participants into tertiles of circulating folate, B 6 , and B 12 concentrations and analyzed the influence of eNOS gene polymorphisms in relation to these variables. We found that the eNOS Ϫ786TϾC polymorphism, but not 894GϾT and 4a4b, influences plasma Hcy concentrations in persons with circulating vitamin concentrations within the relevant reference intervals (Table 4) . We observed that the eNOS Ϫ786C variant did influence Hcy in persons carrying the TC and CC genotypes, but not homozygotes for the rare MTHFR T variant (Table 4) .
We also evaluated the association between eNOS polymorphisms and Hcy, stratifying the whole population by smoking habits. The eNOS Ϫ786TϾC polymorphism, but not 894GϾT and 4a4b, influenced Hcy concentrations in nonsmokers [for Ϫ786TϾC, OR ϭ 2.2 (95% CI, 1.2-3.9; P ϭ 0.009); for 894GϾT, OR ϭ 0.7 (95% CI, 0.4 -1.3; P ϭ 0.3); for 4a4b, OR ϭ 1.7 (95% CI, 0.9 -3.2; P ϭ 0.1)]. For smokers, we found no influence of any of the eNOS polymorphisms on having Hcy in the third tertile. As far as age is concerned, we observed that eNOS Ϫ786TϾC significantly influenced Hcy concentrations in younger persons (age Ͻ60 years; OR ϭ 2.9; 95% CI, 1.3-6.3; P ϭ 0.009), but not in older ones. 
Discussion
In this study we document that the eNOS Ϫ786TϾC polymorphism, but not 894GϾT and 4a4b, represents a new determinant of Hcy concentrations in nonsmokers, in normal vitamin status, in persons Ͻ60 years of age, and in persons not carrying the MTHFR TT genotype, in the absence of factors known to modulate Hcy. Actually, the eNOS Ϫ786C rare variant of this polymorphism in the promoter region has a functional role by lowering the transcriptional rate of the gene Ͼ50% (17 ) . The presence of this variant is associated with decreased NO concentrations.
Data from the literature suggest that NO may modulate Hcy concentrations directly by inhibiting methionine synthase, which synthesizes methionine from homocysteine and 5-methyltetrahydrofolate (8 ) , and indirectly via folate catabolism by inhibiting the synthesis of ferritin (9 ) , which promotes the oxidative cleavage of folate.
Our findings show that eNOS polymorphisms do not affect Hcy concentrations in persons with low concentrations of circulating vitamins, suggesting that the major modulator of Hcy is an environmental factor, such as vitamin status, in addition to the MTHFR 677CϾT polymorphism and that the eNOS gene accounts for high Hcy concentrations when the other variables known to influence Hcy are not present. Similarly, with regard to another environmental factor, smoking habits, we found that eNOS polymorphisms did not modulate Hcy concentrations in smokers.
Our results showed no influence of the 894GϾT polymorphism in exon 7 and of 4a4b in intron 4, which have been proposed to be functionally involved in the transcriptional pathway by modulating plasma Hcy concentrations. Interestingly, we did not find a role for the eNOS 4a4b polymorphism in influencing Hcy concentrations, although it is in close linkage dysequilibrium with the Ϫ786TϾC polymorphism and may have a cis-acting effect on eNOS gene transcription (27 ) .
Regarding the 894GϾT polymorphism, our findings are in line with those reported by Heil et al. (15 ) . and by Chrysohoou et al. (16 ) , but are at variance with those reported by Brown et al. (14 ) , although the prevalence of the rare 894T allele is almost similar. These different results might be attributable to the different folate concentrations and, most importantly, to the adjustment for vitamin B 6 , serum creatinine, and smoking habits in our analysis. Furthermore, experimental studies showed that endothelial production of NO is modified by age (27 ) , which affects folate (28 ) and Hcy concentrations (29 ) . We observed that the Ϫ786TϾC polymorphism does not influence Hcy concentrations in older persons (Ͼ60 years), which suggests that age has a more relevant role than the eNOS gene in modulating Hcy concentrations. To date, this is the first study in which the influence of 3 eNOS polymorphisms on Hcy has been analyzed, thus providing an extended evaluation of the genetic influence of the eNOS gene in modulating Hcy.
Our results provide evidence that, in addition to the MTHFR 677CϾT polymorphism, which is involved in the methionine pathway and is known to influence Hcy concentrations (30 ) , the eNOS gene may represent a new modifier gene modulating plasma Hcy in nonsmokers, in normal vitamin status, and persons Ͻ60 years of age.
The study has two limitations. The first is the lack of information about the methionine synthase A2756G and methionine synthase reductase A66G polymorphisms involved in methionine metabolism. However, their interaction with the eNOS gene in affecting Hcy concentrations was not observed by Brown et al. (14 ) . The second limitation is that the association between the eNOS Ϫ786C variant and Hcy concentrations was not statistically significant because the cohort was divided into 4 or 5 groups based on Hcy concentrations. This could be explained by the only mild biological relevance of these polymorphisms on influencing plasma Hcy concentrations, as otherwise seen by the modest association revealed in the statistical analysis.
In conclusion, our findings highlight another mechanism that can influence the complex methionine pathway. The role of the eNOS Ϫ786TϾC polymorphism, as a determi- 
